The Company nurtures a vision to continuously globalize the intellectual property assets and enhance value of its shareholders, its associates while providing quality products to its clients. The Company has grown from a very humble beginning and has ambitious plans to grow while retaining quality leadership in antibiotics, lifestyle disease drugs.The corporate plans are to ensure growth through forging various joint ventures and strategic alliances and to maximize the revenues and reach.

Develop a broad portfolio and emerge as a leading player in Global High Quality Innovative specialty formulations processes and intellectual properties and become a significant player, especially in the regulated markets. It is the endeavor of the Company to achieve this by resolving complex chemistry challenges, improving process efficiencies, adopting global scale manufacturing and using cost effective market networks and to achieve this, the Company also has on it anvil, plans to make tie up the various places in far east and Europe to extend its reach over larger geographical areas.